Craft

ElectroCore

Stock Price

$11.1

2024-10-29

Market Capitalization

$71.2 M

2024-10-28

Revenue

$32 M

FY, 2025

ElectroCore Summary

Company Summary

Overview
ElectroCore is a bioelectric medicine healthcare company, which develops a non-invasive self-administered Vagus Nerve Stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, respiratory, gastroenterology, and headaches. It focuses on primary headaches, such as migraine and cluster and trials in epilepsy, gastric motility disorders, depression, and anxiety. The Company sells its products to patients through healthcare professionals in the United Kingdom, Germany, Italy, Australia, and Canada.
Type
Public
Status
Active
Founded
2005
HQ
Rockaway, NJ, US | view all locations
Website
https://www.electrocore.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Peter S. Staats

    Peter S. Staats, Chief Medical Officer

  • Brian Posner

    Brian Posner, Chief Financial Officer

  • Thomas J. Errico

    Thomas J. Errico, Chairman, Founder and Principal Investor, Chair, Nominating and Governance Committee

    • Joshua Lev

      Joshua Lev, Vice President, Business Development, Strategy, & Financial Planning

    LocationsView all

    6 locations detected

    • Rockaway, NJ HQ

      United States

      200 Forge Way #205

    • Bernards, NJ

      United States

      150 Allen Rd #201, Basking Ridge

    • Parksville, British Columbia

      Canada

      Rathtrevor Parking Lot 2

    • Geretsried, Bayern

      Germany

      Amberger Straße 1-3

    • Hamburg, Hamburg

      Germany

      214 Weg beim Jäger

    • Yeadon

      United Kingdom

      Unit 4-7 Gateway Drive

    ElectroCore Financials

    Summary Financials

    Revenue (Q1, 2026)
    $9.6M
    Gross profit (Q1, 2026)
    $8.4M
    Cash (Q1, 2026)
    $4.9M
    EBIT (Q1, 2026)
    ($5.3M)
    Enterprise value
    $75.8M

    Footer menu